Novo Nordisk Starts Selling Bonds to Fund Akero Acquisition
Novo Nordisk A/S is tapping the euro bond market with a multi-tranche sale expected to raise about €3.5 billion ($4.1 billion), as the Danish drugmaker seeks funding for its planned...
By Helene Durand · Bloomberg Markets
Novo Nordisk A/S is tapping the euro bond market with a multi-tranche sale expected to raise about €3.5 billion ($4.1 billion), as the Danish drugmaker seeks funding for its planned purchase of US biotech Akero Therapeutics Inc.